Amanda S. Marshall
Former U.S. Attorney
(Local Counsel)
Lynette Byrd
Former Assistant
U.S. Attorney
Roger Bach
Former Special
Agent
(OIG & DEA)
Joe Brown
Former U.S. Attorney
Dr. Nick Oberheiden
Attorney & Founder
DEA Touts “Surge” Leading to 28 Arrests and 147 Revoked Registrations Involving Opioid Prescription Practices
In collaboration with the Department of Justice (DOJ) and other federal law enforcement agencies, the Drug Enforcement Administration (DEA) has been aggressively targeting healthcare providers suspected of improperly prescribing and dispensing opioid medications. This renewed focus began with the DOJ’s announcement of a new Opioid Fraud and Detection Unit last...
Read more
Understanding the DEA’s Diversion Control Program
In the context of prescription drug fraud and federal drug crimes, "diversion" refers to the practice of getting controlled substances and the chemicals used to manufacture illegal drugs into the hands of people who may abuse them. [caption id="" align="alignleft" width="280"] Attorney Lynette S. Byrd DEA Diversion Team Lead Former...
Read more
Understanding the Two Types of DEA Search Warrants
Last Updated: 2023-03-05 For healthcare providers that administer, dispense, and prescribe, controlled-substance medications, the legal risks of non-compliance with the Controlled Substances Act and other federal healthcare laws include the risk of investigation by the Drug Enforcement Administration (DEA). The DEA, which frequently works in collaboration with the Department of...
Read more
What Is a DEA Order to Show Cause?
If you are registered with the Drug Enforcement Administration (DEA) or if you have recently applied for DEA registration, you may have received an Order to Show Cause. An Order to Show Cause represents the initiation of formal administrative proceedings to revoke, suspend, or deny a DEA registration. It is...
Read more
When Does the DEA Get Involved in Healthcare Fraud Cases?
Healthcare fraud investigations can involve many different federal agencies. From investigative and law enforcement agencies such as the Federal Bureau of Investigation (FBI) and Department of Justice (DOJ) to agencies that administer government benefit programs (such as the Centers for Medicare and Medicaid Services (CMS) and the Department of Labor...
Read more
Federal Investigations of MSOs
Business Owners Under Investigation, Physician Licenses at Stake Management Services Organizations (MSOs) have served as a popular tool to seemingly legitimize physician-business joint ventures. The idea was simple: physicians own a portion in a company to which they do not refer any business, but, in return, receive prorated ownership distribution...
Read more
What Can Turn a Lawyer into a Target?
Contact Federal Criminal Defense Attorneys at Oberheiden P.C. to Make Sure Your Law License and Your Freedom Are Protected When the FBI Investigates You Given the number of lawyers in the United States, criminal prosecutions of lawyers appear to be a statistical anomaly. Obviously, any lawyer can be charged just...
Read more
Criminal Prosecutions of Psychiatrists
Benefit from Attorney Dr. Nick Oberheiden's Immense Healthcare Law Defense Experience: Hundreds of Audits and Federal Criminal Cases Against Doctors Resolved with No Charges: 888-680-1745 Dr. Nick Oberheiden is a federal criminal defense attorney routinely chosen by medical providers and business owners to avoid or defend against healthcare fraud allegations....
Read more
What Are the Rules of Stark Law?
Physicians who bill Medicare and Medicaid for patient services are subject to numerous laws that are designed to prevent fraud, waste, and abuse in the federal healthcare reimbursement system. One of these laws is the Stark Law, which imposes substantial civil penalties for unlawful "self-referrals." As a physician, understanding the...
Read more
What Physicians Need to Know About Lack of “Medical Necessity” Prosecutions
OIG, FBI, and DEA Agents Are Targeting Pharmacies—Your Pharmacy May Be Next Pharmacy owners have long heard of the raids, prosecutions, and indictments that occurred in the context of Tricare compound pharmacy investigations. Indeed, the years of 2016 and 2017 have seen a major enforcement action against those physicians, marketers,...
Read more